Association between antiphospholipid antibodies, rheumatic-immune inflammation, and coronary in-stent restenosis
Baseline aPL seropositivity and higher IL-6 were associated with 12-month ISR and clinically driven TLR. Incorporating these immune markers improves risk discrimination beyond clinical and angiographic factors. External validation and interventional studies are warranted.
Authors
- Fei Ye
- Ting Xiong (ORCID: https://orcid.org/0009-0000-7404-4880)
- Pan Chang
- Wei You (ORCID: https://orcid.org/0000-0003-1852-1579)
- Zhiming Wu
- Gaofeng Wang
- Wenxing Mao
Institutions
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fcvm.2025.1656305
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00